Comparison
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840 vs 4 Hydroxyphenylacetic Aciduria C1848680
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Testicular 17 20 Desmolase Deficiency and 4 Hydroxyphenylacetic Aciduria for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
A rare genetic condition where the testes cannot make enough testosterone due to an enzyme deficiency. This affects genital development and puberty. Treatment includes hormone therapy and may involve surgery.
4 Hydroxyphenylacetic Aciduria C1848680
A metabolic disorder where the body cannot properly break down certain amino acids. Typically detected in infancy through screening. Treated with dietary modifications and monitoring.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
0-16
4 Hydroxyphenylacetic Aciduria C1848680
Variable
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
severe
4 Hydroxyphenylacetic Aciduria C1848680
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
Chronic
4 Hydroxyphenylacetic Aciduria C1848680
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
No
4 Hydroxyphenylacetic Aciduria C1848680
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
reproductive
4 Hydroxyphenylacetic Aciduria C1848680
metabolic
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
endocrine
4 Hydroxyphenylacetic Aciduria C1848680
metabolic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-testicular-17-20-desmolase-deficiency-C1839840 and 4-hydroxyphenylacetic-aciduria-C1848680 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840 | 4 Hydroxyphenylacetic Aciduria C1848680 | Discriminating power |
|---|---|---|---|
| Genital or pubertal development | May show atypical genital development or delayed puberty from reduced testicular testosterone. | No established effect on genital development is described. | High |
| Metabolic presentation | Not described as an amino-acid breakdown disorder. | May present through an abnormal urine metabolite, often identified in infancy. | High |
| System involved | Primarily reproductive and endocrine. | Primarily metabolic. | Moderate |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840 when
Atypical genital development in a 46,XY infant
The supplied description centers on impaired testicular testosterone production.
Moderate
Absent or incomplete puberty
Pubertal effects are specifically described for the left condition.
Moderate
Suspected steroid-enzyme deficiency
The named enzyme defect supports endocrine rather than amino-acid evaluation.
High
Choose 4 Hydroxyphenylacetic Aciduria C1848680 when
Abnormal newborn metabolic screen
The right condition is typically detected through infancy screening.
Moderate
Elevated 4-hydroxyphenylacetic acid
This is a biochemical result requiring confirmation and clinician interpretation, not a diagnosis by itself.
High
Concern about amino-acid metabolism
The source describes impaired breakdown of certain amino acids.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840 | 4 Hydroxyphenylacetic Aciduria C1848680 | Interpretation |
|---|---|---|---|
| Karyotype and endocrine assessment | 46,XY context with evidence of reduced testicular androgen production may be sought. | No characteristic karyotype or sex-steroid pattern is established. | Endocrine results require specialist correlation; exact cutoffs are not supplied. |
| Urine organic-acid analysis | No characteristic organic aciduria is described. | May show 4-hydroxyphenylacetic aciduria, but elevation alone is not definitive. | Confirm the finding and consider broader metabolic causes. |
| Genetic or enzyme evaluation | Testing may target the relevant steroidogenic pathway when clinically indicated. | Evaluation depends on the suspected metabolic pathway and is not specified here. | A positive biochemical result should not be equated with a confirmed genetic diagnosis. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
- Outcome
- Chronic condition; long-term outcome is individualized and not quantified here.
- Factors
- Degree of androgen deficiency, timing of care, and response to hormone or surgical management.
4 Hydroxyphenylacetic Aciduria C1848680
- Outcome
- Often described as moderate, but prognosis is not established from these data.
- Factors
- Underlying metabolic cause, dietary adherence, and monitoring.
Time frame: Childhood through adulthood; exact timelines are not supplied.
Early recognition and specialist follow-up may influence management, but outcomes cannot be predicted here.
Complications comparison
| Complication | Presentation |
|---|---|
| Development-related effects | Genital development, puberty, and fertility may be affected. Such effects are not established by the supplied data. Individual outcomes vary and need specialist assessment. |
| Metabolic imbalance | Not described as the primary problem. Impaired amino-acid handling may require dietary management and monitoring. Severity and complications are not quantified in the source. |
| Treatment-related burden | Hormone therapy and possible surgery may be considered. Dietary modification and monitoring are described. No doses, surgical indications, or outcome rates are established here. |
Patient education highlights
- HighDifferent conditions
These conditions affect different systems and are not alternative names for one diagnosis.
- HighAbnormal result versus diagnosis
A urine metabolite abnormality needs confirmation and clinical interpretation before a diagnosis is made.
- MediumSpecialist care
Endocrine or metabolic specialists should guide testing, counseling, and treatment decisions.